Tevogen Bio Holdings Inc. (NASDAQ:TVGNW – Get Free Report) saw a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 248,625 shares, a growth of 141.4% from the October 15th total of 102,979 shares. Based on an average daily volume of 672,098 shares, the short-interest ratio is currently 0.4 days.
Tevogen Bio Stock Down 0.2%
TVGNW stock opened at $0.04 on Friday. Tevogen Bio has a 52 week low of $0.03 and a 52 week high of $0.12. The business has a 50-day simple moving average of $0.06 and a 200 day simple moving average of $0.05.
Tevogen Bio Company Profile
Tevogen Bio is a clinical-stage biotechnology company developing precision T-cell therapies. Its approach uses selected donor-derived T cells designed to recognize specific targets, with the goal of developing treatments for cancer and infectious diseases. The company’s pipeline includes investigational cell therapy candidates, including programs directed at viral targets. Tevogen also describes its ExacTcell platform as supporting the identification and development of targeted T-cell therapies.
Further Reading
- Five stocks we like better than Tevogen Bio
- Costco’s Record $30 Dividend Shows Just How Strong Its Cash Machine Is
- Heavy Lifting: Can USA Rare Earth Turn Its First Sales Into Big Profits?
- These 3 Stocks Have Bought Back Billions, But Which Offers the Best Value?
- Golden Dome’s $185 Billion Question: Who Actually Gets Paid?
Receive News & Ratings for Tevogen Bio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tevogen Bio and related companies with MarketBeat.com's FREE daily email newsletter.
